Alcon buys majority stake in IPO-seeking cell therapy startup Aurion

The share acquisition is the latest twist in a dispute between Alcon and fellow Aurion shareholder Deerfield Management over the direction of the company, which filed to go public in January. 

Related posts

SEAWARD Africa to provide coordinated framework for Ocean Decade Roadmap implementation – Akpan – EnviroNews

March 31, 2025

G20+ countries hold key to global renewable target by 2030 – EnviroNews

March 31, 2025

Source link